Validation and Characterization of Five Distinct Novel Inhibitors of Human Cytomegalovirus-Reference-Cited by-同舟云学术

Validation and Characterization of Five Distinct Novel Inhibitors of Human Cytomegalovirus

Published:2020-03-19 Issue:8 Volume:63 Page:3896-3907
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kapoor Arun¹,Ghosh Ayan K.¹,Forman Michael²,Hu Xin³,Ye Wenjuan³,Southall Noel³,Marugan Juan³,Keyes Robert F.⁴,Smith Brian C.⁴^ORCID,Meyers David J.⁵,Ferrer Marc³,Arav-Boger Ravit¹⁶^ORCID

Affiliation:

1. Department of Pediatrics, Division of Infectious Disease, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States

2. Department of Pathology, Johns Hopkins University, Baltimore, Maryland 21287, United States

3. National Center for Advancing Translational Sciences (NCATS), National Institute of Health, Bethesda, Maryland 20850, United States

4. Department of Biochemistry, Program in Chemical Biology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States

5. Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

6. Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, United States

Funder

National Institute on Deafness and Other Communication Disorders

Flight Attendant Medical Research Institute

National Institutes of Health

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b01501

Reference41 articles.

1. Seroprevalence of Cytomegalovirus Infection in the United States, 1988-1994

2. Betaherpesviruses in transplant recipients

3. Cytomegalovirus Infection and HIV-1 Disease Progression in Infants Born to HIV-1–Infected Women

4. The effect of CMV infection on progression of human immunodeficiency virus disease in a cohort of haemophilic men followed for up to 13 years from seroconversion

5. Cytomegalovirus Seropositivity and Human Immunodeficiency Virus Type 1 RNA Levels in Individuals with Hemophilia

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-Arylpyrimidinamine (Napa) Compounds are Broadly Acting Inhibitors of Human Cytomegalovirus Infection and Proliferation;2024

2. In vitro activity of novel 4-iminohydantoin sulfamide derivatives against human cytomegalovirus;Chemical Papers;2023-09-15

3. Drug Resistance: An Incessant Fight against Evolutionary Strategies of Survival;Microbiology Research;2023-04-06

4. Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus;Antiviral Research;2023-01

5. The Synthesis and Anti-Cytomegalovirus Activity of Piperidine-4-Carboxamides;Viruses;2022-01-25